These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 4792579)

  • 21. [Renal clearance of glucuronized fractions of the bilirubin in various jaundices. IV. Jaundice caused by chronic diffuse liver diseases].
    Díaz-Rubio M; Candel Monserrate I; Díaz-Rubio García M
    Rev Esp Enferm Apar Dig; 1975 Oct; 46(4):377-92. PubMed ID: 1208950
    [No Abstract]   [Full Text] [Related]  

  • 22. Alpha-1 adrenergic receptors in liver plasma membranes of cirrhotic patients with portal hypertension: a quantitative study.
    Zhang Y; Leng X; Zhu J; Peng J; Du R
    Chin Med J (Engl); 1998 Jun; 111(6):507-9. PubMed ID: 11245068
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Enhanced renal clearance of uric acid in hepatic cirrhosis.
    Higuchi T; Nakamura T; Uchino H
    Isr J Med Sci; 1981 Nov; 17(11):1015-8. PubMed ID: 7319788
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Glucose kinetics and splanchnic uptake following mixed meal ingestion in cirrhotic-diabetic subjects.
    Kiwanuka E; Barazzoni R; Tessari P
    Diabetes Nutr Metab; 2001 Dec; 14(6):315-24. PubMed ID: 11853363
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hyperglucagonemia in hepatic cirrhosis: its relation to hepatocellular dysfunction and normalization on recovery.
    Kabadi UM; Eisenstein AB; Tucci J; Pellicone J
    Am J Gastroenterol; 1984 Feb; 79(2):143-9. PubMed ID: 6364796
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Further evidence for the superiority of a 3-compartmental model for distribution analyses of i.v. injected bile acids in men: studies in patients with liver diseases.
    Klapdor R
    Acta Hepatogastroenterol (Stuttg); 1979 Feb; 26(1):23-5. PubMed ID: 425798
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Adrenoceptors in the hepatic tissues in cirrhotic rats and cirrhotic patients with portal hypertension].
    Feng H; Leng X; Zhang Z
    Zhonghua Yi Xue Za Zhi; 1997 Mar; 77(3):175-7. PubMed ID: 9596953
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Human liver regeneration: hepatic energy economy is less efficient when the organ is diseased.
    Mann DV; Lam WW; Hjelm NM; So NM; Yeung DK; Metreweli C; Lau WY
    Hepatology; 2001 Sep; 34(3):557-65. PubMed ID: 11526542
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of antidiuretic hormone on the disappearance of exogenous bilirubin in the plasma.
    Lechin F; Van der Dijs B; Bentolila A; Peña F
    Acta Gastroenterol Latinoam; 1972; 4(4):147-52. PubMed ID: 4664511
    [No Abstract]   [Full Text] [Related]  

  • 30. [Mathematic models of the kinetics of bilirubin and their clinical use].
    Frezza M; Cobelli C; Pozzato G
    G Clin Med; 1979 Feb; 60(2):90-111. PubMed ID: 456782
    [No Abstract]   [Full Text] [Related]  

  • 31. Quantitative studies of the delivery of hepatic-synthesized bilirubin to plasma utilizing -aminolevulinic acid-4- 14 C and bilirubin- 3 H in man.
    Jones EA; Shrager R; Bloomer JR; Berk PD; Howe RB; Berlin NI
    J Clin Invest; 1972 Sep; 51(9):2450-8. PubMed ID: 4639027
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hepatic parenchymal cell volume and the indocyanine green tolerance test.
    Hashimoto M; Watanabe G
    J Surg Res; 2000 Aug; 92(2):222-7. PubMed ID: 10896825
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Bilirubin output and clearance in isolated dog liver perfusion.
    Royer M; Ortiz G
    Acta Hepatosplenol; 1971; 18(4):312-20. PubMed ID: 5110096
    [No Abstract]   [Full Text] [Related]  

  • 34. Circulating transforming growth factor beta(1) as an indicator of hepatic function impairment in liver cirrhosis.
    Flisiak R; Pytel-Krolczuk B; Prokopowicz D
    Cytokine; 2000 Jun; 12(6):677-81. PubMed ID: 10843744
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Caffeine clearance study in hepatocellular carcinoma.
    Tangkijvanich P; Wittayalertpanya S; Kusonsolboon T; Thong-Ngam D; Mahachai V
    J Med Assoc Thai; 1999 Mar; 82(3):297-303. PubMed ID: 10410486
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Processing of protein glycation, oxidation and nitrosation adducts in the liver and the effect of cirrhosis.
    Ahmed N; Thornalley PJ; Lüthen R; Häussinger D; Sebekova K; Schinzel R; Voelker W; Heidland A
    J Hepatol; 2004 Dec; 41(6):913-9. PubMed ID: 15582123
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Hepatic clearance of endogenous bilirubin following Sadamine(xanthinol niacinate) loading in brucellosis-induced hepatocellular damage and in chronic hepatitis].
    Juszczyk J; Kiczka W; Adamek J; Kryska A; Salwa W; Biczysko W; Zengteler G; Swietlicka-Grala J
    Pol Tyg Lek; 1975 Aug 4-11; 30(31-32):1303-5. PubMed ID: 1161569
    [No Abstract]   [Full Text] [Related]  

  • 38. Carnitine metabolism in patients with chronic liver disease.
    Krähenbühl S; Reichen J
    Hepatology; 1997 Jan; 25(1):148-53. PubMed ID: 8985281
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmacokinetics of oxaliplatin in patients with severe hepatic dysfunction.
    Baur M; Drescher A; Gneist M; Dittrich C; Jaehde U
    Cancer Chemother Pharmacol; 2008 Jan; 61(1):97-104. PubMed ID: 17396265
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Multicompartmental analysis of 2- and 3 exponential plasma disapperance curves following single i.v. injection of C14-cholic acid, bromosulfophthalein and 14C-bilirubin and their importance for quantitative studies of the excretory liver function].
    Klapdor R; Eppers J
    Z Gastroenterol; 1974 Feb; 12(1):1-8. PubMed ID: 4440041
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.